AU2011100482A4 - Nasal Spray Human Growth Hormone - Google Patents
Nasal Spray Human Growth HormoneInfo
- Publication number
- AU2011100482A4 AU2011100482A4 AU2011100482A AU2011100482A AU2011100482A4 AU 2011100482 A4 AU2011100482 A4 AU 2011100482A4 AU 2011100482 A AU2011100482 A AU 2011100482A AU 2011100482 A AU2011100482 A AU 2011100482A AU 2011100482 A4 AU2011100482 A4 AU 2011100482A4
- Authority
- AU
- Australia
- Prior art keywords
- dna
- growth hormone
- human growth
- nasal spray
- spray human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Abstract A method to prepare Human Growth Hormone in a form suitable for improved absorption.
Description
1 Description Human growth hormone ( HGH ), in the medical sense, is a protein based peptide hormone. It stimulates growth, cell reproduction and regeneration in humans. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland. HGH is used as prescription drug in medicine to treat children's growth disorders and adult growth hormone deficiency. It is currently only administered by subcutaneous injection. The chemical process of forming synthetic HGH as used in medications is known as' recombinant DNA technology'. Recombinant DNA (rDNA) molecules are nucleic acid sequences that result from the use of laboratory methods to bring together genetic material from multiple sources, creating sequences that would not otherwise be found in biological organisms. Recombinant DNA is made possible because DNA molecules from all organisms share the same chemical structure; they differ only in the sequence of nucleotides within that identical overall structure. Therefore, when DNA from a foreign source is hooked up to host sequences that can drive DNA replication and then introduced into a host organism, the foreign DNA is replicated along with the host DNA. The DNA sequences used in the construction of recombinant DNA molecules can originate from any species. For example, plant DNA may be joined to bacterial DNA, or human DNA may be joined with fungal DNA. In addition, DNA sequences that do not occur anywhere in nature may be created by the chemical synthesis of DNA, and incorporated into recombinant molecules. Using recombinant DNA technology and synthetic DNA, literally any DNA sequence may be created and introduced into any of a very wide range of living organisms.
2 This recombinant DNA technology is the process used to create synthetic HGH ready for injection. Time Medical has adapted this process and has devised a method by which to further break down the amino acid sequence into a liquid form that can be absorbed into the nasal passage by using a nasal spray, completely eradicating the need to administer HGH by injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100482A AU2011100482A4 (en) | 2011-04-28 | 2011-04-28 | Nasal Spray Human Growth Hormone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100482A AU2011100482A4 (en) | 2011-04-28 | 2011-04-28 | Nasal Spray Human Growth Hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2011100482A4 true AU2011100482A4 (en) | 2011-06-30 |
Family
ID=45419812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011100482A Ceased AU2011100482A4 (en) | 2011-04-28 | 2011-04-28 | Nasal Spray Human Growth Hormone |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2011100482A4 (en) |
-
2011
- 2011-04-28 AU AU2011100482A patent/AU2011100482A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL296037A (en) | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | |
| US20200261599A1 (en) | Nucleic acid products and methods of administration thereof | |
| CA2916081C (en) | Methods and non-immunogenic compositions for treating inflammatory disorders | |
| KR102589415B1 (en) | Method and system for growing cell cultures while preventing lactate accumulation | |
| US9758806B2 (en) | Acellular compositions for treating inflammatory disorders | |
| EP3450557A1 (en) | Novel anti-transferrin receptor antibody that passes through blood-brain barrier | |
| US20190161543A1 (en) | Modulation of afucosylated species in a monoclonal antibody composition | |
| US20160136245A1 (en) | Methods of treating pain using protein solutions | |
| Dirnberger | A guide to efficient keyword, sequence and classification search strategies for biopharmaceutical drug-centric patent landscape searches-A human recombinant insulin patent landscape case study | |
| US20190048070A1 (en) | Reduction of high molecular weight species, acidic charge species and fragments in a monoclonal antibody composition | |
| Kulubya et al. | The unique properties of placental mesenchymal stromal cells: a novel source of therapy for congenital and acquired spinal cord injury | |
| CN101020715A (en) | Process of extracting and preparing deer nerve growth factor (DEER NGF) | |
| CN105732789A (en) | Haemadipsa sylvestris analgesic peptide mh2620 and gene and application thereof | |
| AU2011100482A4 (en) | Nasal Spray Human Growth Hormone | |
| Zand et al. | A review article Biotechnology Applications in Medicine | |
| ES2750685T3 (en) | Transformant used to lose weight and reduce fat, construction procedure for transformant and application of transformant | |
| AU2021412922A1 (en) | Use of hrpn-type multi-mimotope epitope ligand protein in foods, cosmetics, health care products or pharmaceuticals | |
| CN101302529A (en) | Transgenic neural stem cell co-expressing GDNF and BDNF | |
| Sinow | Construction of an IGF-NAGLU Fusion Protein for Treatment of Sanfilippo B Syndrome | |
| Rizvanov et al. | Advancing modern equine medicine using gene therapy | |
| Uddin | Regenerative medicine | |
| Dabhole | Recent innovations in therapeutic recombinant protein | |
| CN101445560A (en) | Method for preparing fusion protein used for livestock and poultry | |
| CN101812135B (en) | Fusion protein with high-efficient platelet-increasing role and preparation method thereof | |
| Behera | Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGI | Letters patent sealed or granted (innovation patent) | ||
| MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |